MAGNETOM World

Clinical Talks

Experience the talks we have captured during various Workshops and Events.

How is 7T MRI changing the game in epilepsy

2023-09-08

Maxim Guye, MD, PhD (Centre for MR in Biology and Medicine, Aix-Marseille University & University Hospital, Marseille, France)

How high-performance gradients provide new insights into neurological disease

2023-09-08

Susie Y. Huang, MD, PhD (Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA)

Accelerated, High-Resolution TSE Deep Learning Reconstructions for Pediatric MSK MRI

2023-07-21

Sarah Bixby, M.D., MBA (Boston Children’s Hospital; Harvard Medical School, Boston, MA, USA)

SPR Lunch Symposium 2023

Energy Consumption in Medical Imaging: An Uncomfortable Truth

2023-03-28

Elmar Merkle, M.D. (University Hospital Basel, Switzerland)

ECR 2023

How are Energy Prices Affecting Radiology – and what can we do about it?

2023-03-28

Mike Notohamiprodjo, M.D. (DIE RADIOLOGIE, Munich, Germany)

ECR 2023

Pushing the Boundaries of 7 Tesla and Beyond

2022-05-30

Kâmil Uğurbil, PhD (CMRR, Center for Magnetic Resonance Research, Minneapolis, MN, USA)

ISMRM 2022

Cardiac Triggering without ECG: From Research to Clinical Routine?

2022-05-25

Orlando P. Simonetti, Ph.D., MSCMR, FISMRM (The Ohio State University, Columbus, OH, USA)

ISMRM 2022

High Bandwidth Inversion Recovery: Extending the Benefits of CMR to Patients with Cardiac Devices

2022-02-08

Hajnalka Vágó, M.D., Ph.D. (Heart and Vascular Center, Semmelweis University, Budapest, Hungary)

SCMR 2022

The Siemens Healthineers Prostate Cancer AI Detection Software in Clinical Practise

2021-10-21

Anwar R. Padhani MB, BS, FRCP, FRCR
(Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London, UK)

PET-MRI for Radiotherapy Planning in Head and Neck Cancer Patients

2021-10-12

Anders Beck Olin, PhD (Rigshospitalet, Copenhagen, Denmark)

AI in PET-MR Imaging: Attenuation Correction and Motion Correction

2021-10-12

Hongyu An, D. Sc (Washington University, St. Louis, MO, USA)

Role of Abbreviated Breast MRI in Screening Women with Dense Breasts: Patient’s Perspective

2021-09-21

Susan Weinstein, MD (Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA)

ECR Breast Care Symposium 2021

Listen – Discuss – Share

11th MAGNETOM World Summit
Lectures on Demand

Preview Clinical Talk Krishna S. Nayak, Ph.D.

Next Generation 7T MRI Brain Scanner for High-Res Imaging

2021-06-10

David A. Feinberg, Ph.D., M.D. (University of California, Berkeley, CA, USA)

ISMRM Lunch Symposium 2021

Preview Clinical Talk Michael Hansen, Ph.D.

The Connected Imaging Instrument

2021-06-10

Michael Hansen, Ph.D. (Microsoft Corporation, USA)

ISMRM Lunch Symposium 2021

The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.

The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.

Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.

MAGNETOM 7T and 9.4T are ongoing research. All data shown are acquired using non-commercial systems under institutional review board permission. Siemens does not intend to commercialize the systems. MAGNETOM Terra is currently under development and is not for sale in the US and in other countries. Its future availability cannot be ensured.

The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens.

MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.